Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or colleague who's taken it and raved about the metabolic results they've seen ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Switching From Tirzepatide to semaglutide for weight loss? This article was reviewed by Lynn Marie Morski, MD, JD. Key takeaways: You can switch from tirzepatide to ...

The runaway popularity of GLP-1 medications like Ozempic and Wegovy for weight loss and diabetes management led to a nationwide shortage that lasted more than a year—and created the perfect conditions ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end up taking GLP-1 receptor agonists like Ozempic or Wegovy for an extended ...

Whether you’ve just started taking semaglutide for weight loss or are considering other GLP-1 medications, you likely have many questions. These include the optimal dose, when to slow down or increase ...

Danish drugmaker Novo Nordisk A/S was at the forefront of the weight-loss injection boom as people discovered that its ...

WeGovy is the first oral GLP drug for weight loss that will be on the market. The daily pill contains 25 milligrams of ...

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...